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Abstract
Purpose To establish the antioxidant status of
the aqueous humour in glaucoma associated
with exfoliation syndrome (XFG) and to
compare it to primary open-angle glaucoma
(POAG) and cataract patients.
Methods Patients were diagnosed with
POAG, XFG, or cataract (n¼ 25 for each group).
Total reactive antioxidant potential (TRAP)
was measured by chemiluminescence.
Ascorbic acid levels and the activities of
catalase, glutathione peroxidase (GPx), and
superoxide dismutase (SOD) were measured
spectrophotometrically.
Results TRAP value was lower in XFG
(28±2 lM Trolox) than in POAG (55±8 lM
Trolox; Po0.001). TRAP values in both
glaucomas were lower than the cataract value
(124±5 lM Trolox; Po0.001). A decrease in
ascorbic acid was measured in XFG
(230±20 lM) compared with POAG
(415±17 lM; Po0.001). Ascorbic acid in both
glaucomas was lower than in cataract
(720±30 lM; Po0.001). A significant increase
in GPx was found in XFG (30±2 U/ml)
compared with POAG (16±3 U/ml). GPx
activity in both glaucomas was increased
when compared with cataracts (6±2 U/ml;
Po0.001). A significant increase of 67% in
SOD activity was observed in the glaucoma
group vs cataract group (27±3 U/ml; Po0.001),
but no changes were found between both
glaucomas.
Conclusions The antioxidant status of the
aqueous humour may play a role in the
pathophysiology of both glaucomas.
Eye (2009) 23, 1691–1697; doi:10.1038/eye.2008.352;
published online 21 November 2008
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Introduction
Exfoliation syndrome (XFS) is the most common
cause of secondary open-angle glaucoma.1 It is a
generalized age-related disorder of the
extracellular matrix with abnormalities in the
basal membranes.2
The clinical diagnosis is made by the presence
of exfoliative material on the surface of the
anterior capsule of the lens. Exfoliative material
may also be present in the corneal endothelium
and the trabecular meshwork. Other clinical
features include atrophy of the pupillary border
and iris transillumination defects.3
Exfoliation syndrome may be associated with
ocular problems such as high intraocular
pressure (IOP) and glaucomatous optic
neuropathy. It may also be associated with poor
mydriasis, zonular instability, corneal
endotheliopathy, central retinal vein occlusion,
and cataract.2,3 Systemic associations found in
XFS include angina pectoris, hypertension,
myocardial infarction, and stroke.4
The exact aetiology and pathogenesis are
unknown. The most accepted theory postulates
that it is an age-related process of build-up of an
abnormal elastotic material.5
The principal ocular cells implicated in the
production of exfoliative material are those
closely associated with the aqueous humour
circulation, and they are influenced by the
substances present in it. An investigation of the
qualitative and quantitative alterations of the
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aqueous humour composition might, therefore, provide an
important insight into the factors involved in this disorder.
Recent studies reported differences in the concentration
of matrix metalloproteinases and growth factors in the
aqueous humour of XFS patients. It is well known that
growth factors and proteases can be activated by free
radicals, so the occurrence of oxidative stress and therefore
the antioxidant status of the aqueous humour may play a
role in the oxidative metabolism of the cells implicated in
the production of exfoliative material.6–8
Oxidative stress can be defined as an increase in the
intracellular concentrations of reactive oxygen species
(ROS) over physiological values.9 This situation may be
reflected by changes in the antioxidant defences that can
be depleted because of the ROS action or increased as a
protective response.10
The aqueous humour contains a variety of enzymatic
and non-enzymatic antioxidant defences. Low molecular
weight antioxidants, such as glutathione (GSH), ascorbic
acid, cysteine, and tyrosine, have been identified in the
aqueous humour.11 Ascorbic acid, a molecule capable of
scavenging superoxide anion, hydroxyl radical, and
singlet oxygen,12,13 is present at high concentrations in
aqueous humour (1–2 mM).14,15 Increasing evidence
suggests that ascorbic acid plays an important role in the
defence mechanisms of the ocular tissues against free
radical damage.16,17 A decrease in ascorbic acid and an
increase of 8-isoprostaglandin F2a, a free radical
catalysed arachidonic acid product used as an in vivo
oxidative stress marker, have been reported in the
aqueous humour of patients with XFS.18 Low molecular
weight antioxidants can be determined by total reactive
antioxidant potential (TRAP). This is a measurement of
the ability of a compound to reduce pro-oxidants or
reactive species of pathologic significance. TRAP values
of biological samples can be determined through a
chemiluminescence method, which allows a precise
evaluation over short periods of time.19,20
Antioxidants in the aqueous humour also include
enzymatic systems such as superoxide dismutase (SOD),
catalase, and glutathione peroxidase (GPx).21–23 The
formation of highly cytotoxic oxygen-derived free
radicals is prevented by these enzymes.
The purpose of this study is to evaluate the antioxidant
status of the aqueous humour in patients with glaucoma
associated with XFG and to compare it with primary
open-angle glaucoma (POAG) and cataract patients.
Patients and methods
Patients
The patients were divided into three groups: patients
with XFG, POAG, and cataract. Each group consisted of
25 patients. All patients were Caucasians and matched
for age and sex. There were no statistically significant
differences between the groups in terms of age and sex.
Age was 73±2 years old for the XFG group, 70±10 years
old for the POAG group, and 73±2 years old for the
cataract group.
Preoperative IOP was 25±5 mmHg for the XFG
patients, 26±4 mmHg for the POAG group, and
14±6 mmHg for the cataract group.
Vertical cup/disc ratio was 0.89±0.01 for XFG patients
and 0.89±0.01 for the POAG group.
Inclusion criteria
Glaucoma patients included in the study had a diagnosis
of POAG or XFG. Structural definition: vertical cup-to-
disc ratios (C/D) of 0.7 or more, asymmetry in the C/D
of 0.2 or more and/or thinning of the neuroretinal rim-to-
disc ratio of less than 0.1 with corresponding perimetric
damage. The Disc Damage Likelihood Scale system was
used to evaluate the rim-to-disc ratio.24,25 Functional
definition: glaucoma hemifield test outside normal limits,
and three adjacent points in the 5% level on the pattern
deviation plot, using the 24–2 strategy of the Humphrey
perimeter.24,25 Visual fields were considered reliable if
false-negative and false-positive responses were below
33%. Unreliable visual fields were repeated on the same
day. If the second visual field was also unreliable,
inclusion was made only on the basis of structural
damage.
All individuals had advanced glaucoma and elevated
IOP despite the use of maximum tolerated medical
therapy, and were scheduled for trabeculectomy. Patients
with glaucoma (XFG and POAG) were using a variety of
topical antiglaucoma medications. Maximal tolerated
medical therapy usually included a combination of
timolol-dorzolamide (or timolol and brimonidine),
although we have eliminated patients on prostaglandin
analogues. Antiglaucoma medications were not stopped
before the procedures.
Patients enrolled in the cataract group had senile
cataract. Cataract patients received topical phenylephrine
and tropicamide as dilating drops before surgery. Non-
steroidal anti-inflammatory agents were not
administered before the procedure. All patients in this
group did not have glaucoma. In all cases, this was the
first intraocular surgical procedure.
All patients underwent a complete ophthalmic
examination. This included an anamnesis, best corrected
visual acuity, slit-lamp examination, Goldmann
applanation tonometry, and fundus examination with a
dilated pupil. Gonioscopy was performed in all cases
with a four-mirror goniolens. All patients (POAG and
XFG) had an open angle (grade 3 or 4 of the Shaffer
classification). The optic nerve was evaluated with a 78
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dioptre lens, and the vertical and horizontal C/D ratios
were recorded, as well as the presence of any notch or
haemorrhage, and the appearance of the neuroretinal
rim. Computerized perimetry was performed with the
Humphrey 750, threshold strategy 24–2, or similar
program with the Octopus.
In all glaucoma patients, no other explanation for the
optic nerve damage and the visual field loss should be
found apart from the glaucoma.
Exfoliation syndrome was defined by the presence of
exfoliation material on the anterior surface of the lens.
Exfoliation material was also investigated in the
pupillary border, corneal endothelium, anterior hyaloid,
and angle. However, for the diagnosis of XFS, only the
presence of material in the anterior surface of the lens
was considered. This surface, with the pupil dilated, was
carefully examined for the presence of exfoliative
material, using the high magnification of the slit-lamp
and adequate illumination.
Exclusion criteria
We excluded patients with previous intraocular
surgeries, laser treatment, uveitis, any posterior segment
pathologies, diabetes mellitus, or any other systemic
disease that may have influenced our measurements. We
excluded from this study patients with other ophthalmic
conditions such as angle closure, low tension, congenital
glaucoma, trauma, or pigment dispersion syndrome.
We have eliminated patients on prostaglandin
analogue treatment. None of the patients smoked, had
special diets, or were taking antioxidant vitamins such as
a-tocopherol, ascorbic acid, or non-steroidal anti-
inflammatory agents. The only systemic medications
allowed were those for blood hypertension.
Aqueous humour sampling
Aqueous humour (0.1–0.2 ml) was rapidly and carefully
collected at the beginning of the surgery through a
paracentesis, using a 27-gauge needle connected to a
tuberculin syringe under an operating microscope.
Aqueous humour was immediately cooled at 701C and
transported to the laboratory to run all the assays. All the
samples were protected from light. Samples were
evaluated as soon as possible during the first 24 h after
the surgery.
Biochemical determinations of non-enzymatic
antioxidants
Ascorbic acid
Ascorbic acid concentration in the aqueous humour was
evaluated spectrophotometrically according to the
method described by Kyaw.26 Samples were treated with
phosphotungstic acid (1.36 M) and incubated at room
temperature for 30 min. After centrifugation, the
absorbance of the supernatant was measured at 700 nm.
A standard curve was established with a set of serial
dilutions of ascorbic acid. Results were expressed as mM.
TRAP
Total reactive antioxidant potential was measured by
chemiluminescence in a Luminoskan V 1.2-0 liquid
scintillation counter. The reaction medium consisted of
20 mM 2,2-Azobis (2-amidinopropane) (ABAP) and
40mM luminol. The system was calibrated with different
concentrations of Trolox (0.25–0.50 mM). A comparison of
the induction time after the addition of Trolox and the
aqueous humour allows for calculation of the total
antioxidant capacity (TRAP) as the equivalent of Trolox
concentration necessary to produce the same induction
time.20,27
Biochemical determinations of the antioxidant enzymes
GPx activity
Glutathione peroxidase activity was determined by
following reduced nicotinamide adenine dinucleotide
phosphate (NADPH) oxidation at 340 nm. The reaction
medium consisted of 100 mM phosphate buffer (pH 7.50)
in the presence of 10mM reduced glutathione, 6 U/ml
glutathione reductase, and 10 mM tert-butyl
hydroperoxide. Results were expressed as U/ml of
aqueous humour. One unit corresponds to 1 mmol
NADPH oxidation per minute per ml of aqueous
humour.28
Catalase levels
Catalase activity was determined by measuring the
decrease in absorption at 240 nm in a reaction medium
consisting of 100 mM phosphate buffer (pH 7.20) and
10 mM hydrogen peroxide (H2O2). The results were
expressed as catalase content in fmol/ml of aqueous
humour.29
SOD activity
Superoxide dismutase activity was determined in
aqueous humour samples by measuring the inhibition of
the rate of the autocatalytic adenochrome formation at
480 nm in a reaction medium containing 1 mM
epinephrine and 50 mM glycine/NaOH (pH¼ 10.20).
The enzyme activity was expressed as SOD U/ml of
aqueous humour. One unit is defined as the amount of
enzyme that inhibits the rate of adrenochrome formation
by 50%.30
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All the chemicals were purchased from Sigma Aldrich
Chemical (St Louis, MO, USA).
Data and statistical analysis
Statistical calculations were performed with the
GraphPad InStat statistical package for Windows. Data
are expressed as the mean value±SEM (standard error of
the mean). The statistical significance of the differences
between the XFG and POAG groups was calculated by
the two-tailed unpaired Student’s t-test, and a probability
value of P smaller than 0.01 indicated a statistically
significant difference.
Statement of ethics
We certify that institutional regulations concerning the
ethical use of human volunteers were followed during
this research.
This study was approved by the Human Subjects
Committee of the University of Buenos Aires, and
adhered to the Declaration of Helsinki.
Written informed consent was obtained from all
participants.
Results
A total of 75 aqueous humour samples were analysed, 25
for each of the following groups: patients with XFG,
POAG and cataract. Aqueous humour samples were
compared regarding the alterations in the levels of non-
enzymatic antioxidants with two parameters: ascorbic
acid concentration and the TRAP. The activity of the
antioxidant enzymes GPx, catalase, and SOD was also
measured.
The ascorbic acid concentration in the aqueous
humour was 230±20mM for the XFG group, which
represents a 45% decrease when compared with the
POAG group. The mean value of the POAG group was
415±17mM (Po0.001). Ascorbic acid levels of both
glaucomas were lower than in the cataract group
(720±30 mM; Po0.001) (Figure 1).
On the other hand, the mean values of the TRAP were
found to be 55±8mM Trolox in the aqueous humour of
the POAG group and 28±2mM Trolox in the aqueous
humour of the XFG group. In other words, the levels of
TRAP were significantly decreased (49%) in the aqueous
humour of the XFG group when compared with that of
the POAG group (Po0.001). TRAP values of both
glaucomas were lower than the cataract value
(124±5 mM Trolox; Po0.001) (Figure 2).
The activity of GPx, catalase (CAT) levels, and SOD
activity were determined in the aqueous humour of the
XFG group and compared with those measured in the
POAG and cataract groups. These data are summarized
in Table 1.
A significant increase in GPx activity was found in the
aqueous humour of the XFG group when compared with
that of the POAG group, whereas no significant changes
were found in the CAT levels and SOD activity. GPx
activity in the aqueous humour of the XFG patients
showed an 87% increase when compared with the POAG
group. The mean value of GPx in the aqueous humour
from the XFG group was 30±2 U/ml, and for the POAG
group it was 16±3 U/ml (Po0.001). GPx of both
glaucomas showed an increase when compared with the
cataract group (6±2 U/ml; Po0.001).
Figure 1 Ascorbic acid concentration from the aqueous
humour in patients with glaucoma associated with exfoliation
syndrome (XFG), compared with primary open-angle glaucoma
(POAG) and cataract patients. The values are represented as
mean±SEM for 25 XFG patients, 25 POAG patients, and 25
cataract patients. *Po0.001.
Figure 2 Total reactive antioxidant potential from the aqueous
humour in patients with glaucoma associated with exfoliation
syndrome (XFG), compared with primary open-angle glaucoma
(POAG) and cataract patients. The values are represented as
mean±SEM for 25 XFG patients, 25 POAG patients, and 25
cataract patients. *Po0.001.
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On the other hand, no significant changes were found
in catalase activity. Catalase levels in the aqueous
humour from the XFG and POAG groups showed mean
values of 40±5 and 42±4 fmol/ml, respectively, whereas
in the cataract patients it was 38±7 fmol/ml.
The mean value of SOD in the aqueous humour of the
XFG group was 44±7 vs 42±5 U SOD per ml in the
POAG group. A significant increase of 67% in the SOD
activity was observed in both glaucoma groups vs the
cataract group (27±3 U/ml; Po0.001), but no changes
were found between both glaucomas.
Discussion
The results of the present study suggest that alterations
of the antioxidant defence system are present in the
aqueous humour from patients with glaucoma associated
with XFG as compared with POAG and cataract patients.
To our knowledge, this is the first report that establishes
changes in the antioxidant defence system in the aqueous
humour of patients with XFG or POAG without cataract.
Earlier works have reported alterations in the levels of
antioxidants of aqueous humour of patients scheduled
for phacoemulsification surgery with diagnoses of
pseudoexfoliation syndrome or with coexistent cataract
and glaucoma.31,32
The ascorbic acid levels in XFG patients were
decreased 45% compared with POAG patients. These
findings seem to be significant because ascorbic acid is
essential in cells for its antioxidant capacity and its role in
regenerating vitamin E and glutathione.33 In addition to
the protective role of ascorbic acid against free radical
damage, it also modulates the synthesis of various
extracellular matrix molecules such as collagen, elastin,
laminin, and glycosaminoglycans.34 Thus, alterations in
ascorbic acid concentrations may produce an increase in
the fibrillar material deposits that affect the normal
aqueous flow through the trabecular meshwork.
Significantly reduced levels of ascorbic acid have been
reported in the aqueous humour of exfoliation patients
with cataract, suggesting a faulty antioxidant defence
system.35 Our results are in accordance with these
previously published values despite the fact that our
exfoliation patients were also diagnosed with glaucoma.
In addition to the decrease in ascorbic acid levels, a
significant decay in the aqueous humour TRAP level of
the XFG group was found when compared with the
POAG group. These results indicate a significant
reduction in the concentrations of water-soluble
antioxidants in the aqueous humour, such as glutathione,
ascorbic acid, tyrosine, and cysteine. Homocysteine is a
non-essential sulphur amino acid produced as an
intermediate in the metabolism of cysteine. In recent
studies, the role of homocysteine in the development of
exfoliation glaucoma was investigated.36 The toxicity
mechanism of homocysteine may be because of its
oxidation in the presence of transition metals, generating
superoxide anion, H2O2, hydroxyl radical, and
sulphurated radicals.9 Homocysteine was found to be
elevated in the aqueous humour and the plasma of
patients with XFG coexistent with cataract and normal
IOP.37,38 Moreover, low levels of glutathione were found
in the aqueous humour of patients with XFG coexisting
with cataract and normal IOP.39
The changes measured in our work in non-enzymatic
antioxidants may be because of the occurrence of
oxidative stress in the XFG eye that makes the organ
more susceptible than the POAG eye to the damage
associated with ROS production. In such conditions of
deficient antioxidant non-enzymatic defences, an
increase in the activity of antioxidant enzymes could be
expected as a tissue adaptative response. According to
this, the XFG group presented a higher GPx activity in
the aqueous humour when compared with the POAG
group.
Alterations in GPx activity might have important
consequences on the steady state concentration of H2O2.
The aqueous humour normally contains H2O2, which is
toxic to the cells. Nevertheless, H2O2 is an essential
component of several signal-transduction pathways,40
but when its levels exceed the physiological values, it is
removed by the two antioxidant enzymes, catalase and
GPx. As GPx removes H2O2 using glutathione as a
cofactor, this might contribute to the depletion of
glutathione. Glutathione is involved in ascorbic acid
metabolism, and its depletion produces ascorbyl radicals
that cannot be regenerated to ascorbic acid.9
Our results are consistent with this mechanism, as an
increase in the activity of GPx and a decrease of the
TRAP and ascorbic acid concentration were measured,
providing evidence for a role of free radicals-induced
oxidative damage in XFG. We suggest that this situation
may have been because of a defective redox cycling of
reduced/oxidized glutathione.
Table 1 Antioxidant enzymes activities in the aqueous humour
from primary open-angle glaucoma (POAG), and pseudoexfola-







SOD (U/ml) 44±7a 42±5b 27±3
GPx (U/ml) 30±2a,c 16±3b 6±2
CAT (fmol/ml) 40±5 42±4 38±7
The values are represented as mean±SEM.
aXFG vs cataract, Po0.001.
bPOAG vs cataract, Po0.001.
cXFG vs POAG, Po0.001.
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No significant changes were found in the catalase
levels, and this may be due to the nitric oxide (NO)
inhibition of the catalase because of the union of NO to
the haem group of the enzyme.41 NO competes with
H2O2 for the union to the complex I of the catalase; when
this enzyme is inhibited, H2O2 has to be metabolized by
GPx. GPx activity was found increased and acts as a
compensatory mechanism to ameliorate the oxidative
stress in the aqueous humour of XFG and POAG
patients. Nevertheless, in the present study, we did not
find any statistically significant differences in SOD
activity between the XFG and POAG groups.
It is better to perform oxidative stress assays on
glaucomatous aqueous humour samples that have not
received topical medication. As far as we know, there are
no studies that have evaluated oxidative stress
parameters in the aqueous humour of glaucomatous eye
samples that have not received topical medication for a
reasonable time before sampling. Another issue to be
considered is how many suitable patients in clinical
practice undergo antiglaucomatous surgery without any
antiglaucomatous instillation. It is not precisely known
what effect local medication could have on our results.
We did not find any changes when we tested the effect of
these medications in TRAP values and antioxidant
enzyme activities in vitro.20
In the eye, an altered oxidant/antioxidant balance may
result in a number of molecular changes that contribute
to the development of age-related ocular diseases such as
macular degeneration and glaucoma.42–46 It has been
suggested that the presence of a chronic oxidative stress
situation induced by free radicals can compromise the
trabecular meshwork function.47,48 Our results indicate
that in both glaucoma groups, the activity of SOD is
increased when compared with the cataract group. A
recent study found an increased activity of this enzyme
in patients with cataract associated with XFG vs non-
exfoliative cataract patients.49
Ischaemia produced by changes in IOP and the
resultant decrease of oxygen flow into the tissue may
lead to an increase in intracellular calcium ions
concentration, which may activate proteolysis and lead
to the conversion of xanthine reductase into xanthine
oxidase, which produces superoxide anion and a
compensatory increase in SOD activity.9,50
If oxygen active species are implicated in trabecular
meshwork cell damage, an associated antioxidant
mechanism should be present to repair the oxidative
injury. The defence against the harmful effects of free
radicals is achieved by endogenous antioxidant
compounds and antioxidant enzymes present in the
aqueous humour. The antioxidant status of aqueous
humour might therefore provide an important insight into
the factors involved in the development of glaucoma.
The changes observed in the antioxidant defences in
the aqueous humour suggest a possible role for the active
oxygen species in the tissue damage and pathogenesis of
XFG. Our findings suggest that free radicals action with a
depleted endogenous non-enzymatic defence system
play a role in the worse damage observed in XFG eyes
than in POAG eyes. At any level of IOP, damage in XFG
is worse than in POAG, prognosis is also worse,
progression is more rapid, response to medical therapy is
worse, needs surgery more often, and blinds more
people. Our results would suggest that further research
regarding the use of antioxidants as an adjunct therapy
in glaucoma may be indicated.
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